Introduction
Since 1981, when the first reports about AIDS were published in the medical literature, mucocutaneous diseases have played an important role in the initial diagnosis of HIV infection and in determining the clinical stage of the disease. Skin can serve as the main indicator of other problems. In up to 90% or more of HIV-positive patients, mucocutaneous problems may develop at any stage of the disease (1, 2) . Patients with advanced HIV infection have more skin disorders than those in the early stages. Hence, dermatologic examinations can serve as a guide for diagnosis in terms of severity of HIV/AIDS (1, 3, 4) .
It is well known that mucocutaneous diseases vary among countries, which may be attributable to climate, endemic diseases, and hygienic standards, as well as social, economic, and cultural factors. To date, there have been many reports issued about the dermatologic manifestations of HIV/AIDS patients in Western literature. However, there is a lack of sufficient data about dermatologic findings in Turkish HIV-infected patients. Therefore, our aim in this study was to document the dermatologic manifestations and their relationships with CD4 cell counts among HIV/AIDS patients visiting our clinic for the first time in İstanbul, a large cosmopolitan city situated in western Turkey.
Materials and methods
A total of 306 newly diagnosed HIV/AIDS patients admitted to our outpatient clinic between January 2006 and September 2012 were included in this study. All patients were examined by an infectious diseases specialist, and patients who had skin, mucous membrane, nail, or hair complaints were examined by a dermatologist. All diagnoses were based on clinical criteria supplemented by laboratory procedures.
Information on age, sex, transmission routes, socioeconomic and educational status, CD4 counts, and dermatologic findings were collected retrospectively from medical records. FACSCalibur flow cytometry (Becton Dickinson, USA) and a concurrent complete blood count performed by standard techniques were used to evaluate CD4 T-cell count and CD4/CD8 ratio.
All analyses were performed by using GraphPad Prism 5.0 and SPSS 15.0. Data were described using mean ± standard deviation. Chi-square and Fisher's exact tests were used for categorical variables as appropriate. P < 0.05 was considered to be significant.
Results
Of the 306 HIV/AIDS patients included in this study, 260 (84.9%) were men, with a mean age of 38.3 ± 11.07 years and all patients being of Caucasian origin. The most frequent route of transmission was heterosexual intercourse (65.3%), followed by men having sex with men (MSM) (33.6%); intravenous drug abuse was present in only 3 cases. Almost half of the patients (141 (47.7%)) had low education. The majority of the women (30 (65%)) were housewives, whereas in men, office workers (n = 69), the unemployed (n = 25), and drivers (n = 18) constituted the largest group, at 112 in total (43% Tables 1 and 2. A statistically significant correlation with low CD4 cell counts was found for oral candidiasis, folliculitis, herpes zoster, hyperpigmentation, xerosis, and Kaposi's sarcoma.
Out of 306 patients, 44 (14.3%) had been diagnosed with HIV infection due to mucocutaneous diseases before. Oral candidiasis (n = 18), Kaposi's sarcoma (n = 7), folliculitis (n = 6), and herpes zoster (n = 5) were the most common diseases in these patients.
Discussion
In HIV infection, as a consequence of decline in the number of antigen-presenting cells and CD4 lymphocytes, the skin becomes vulnerable to opportunistic infectious agents and neoplastic disorders (5). Many studies have reported mucocutaneous manifestations in 33%-95% of HIVinfected patients (2, 4, 6, 7) . The prevalence of dermatologic findings among our patients (36.2%) is close to that of reports from Iran and India. The only study from Turkey was published in 2007 and the rate of skin manifestations in HIV/AIDS patients was 90% in that report (8) . The causes of this difference might be that the study in 2007 included inpatients, that the number of the cases was very limited, and that the study was made in a different geographic region in Turkey. Nevertheless, reports from different regions of India declared the cutaneous manifestations to be between the range of 40%-87.6% (6, 9) .
In our study, infectious and noninfectious dermatologic manifestations were recorded (see Tables 1  and 2 ). The most common infections were fungal, with oral candidiasis being the most frequent. Azfar et al. and Spira et al. showed similar rates and results; nevertheless, other studies reported higher incidence rates of oral candidiasis, up to 54.1% (3, 10, 11) . The prevalence of dermatophytosis depends on sociocultural level, climate, clothing, and profession; there is no significant difference between the HIV-negative and HIV-positive population (12) . In our study, dermatophytosis was documented in 5.4% of the patients.
The most common viral infection was herpes zoster, followed by condylomata acuminata. Shobana et al. reported herpes zoster with a frequency of 6%, similar to our study (6) . In previous studies, condylomata acuminata rate was determined as 3.1%-12.8% among HIV-infected patients (13, 14) .
In bacterial infections, as observed in our patients, studies have revealed frequencies of folliculitis ranging from 3.3% to 32.9% (11, 15) . One of the 2 patients with scabies was diagnosed with HIV infection due to the crusted form of this infestation. The rate of scabies infection has been reported to be up to 10%, especially in pruritic eruptions (1) .
Out of all the noninfectious diseases, generalized hyperpigmentation was the most frequent finding observed in patients. Hyperpigmentation incidence has been reported as being low in European populations, but high rates of incidence have been reported in Asian studies (9, 16, 17) . Dry skin has been noted as a common finding in studies ranging from 22% to 73% in HIV-infected patients (3, 9, 10, 17) . The prevalence of xerosis in our patients was considerably lower than in the other studies.
Seborrheic dermatitis may be an early clinical marker for HIV infection and the incidence of disease changes by 14% to 74% (4, 9) . In our patients, seborrheic dermatitis was observed in all stages of HIV infection. Very high incidences of psoriasis have been reported from Asia (up to 25%) in HIV-infected populations (18) . In Western studies, on the other hand, 2%-4% incidences of psoriasis have been published (6) . In this study, psoriasis, lichen planus, and alopecia were also rarely observed.
Compared to its prevalence in the 1980s and early 1990s, the rate of Kaposi's sarcoma was relatively low (19) . Among the HIV-infected patients, MSM were the most affected by Kaposi's sarcoma. In our study, Kaposi's sarcoma was observed in 8 patients, 5 of whom were MSM.
Dermatological manifestations increased both in frequency and severity with progression of HIV and decline in CD4 cell counts. There was a significantly high occurrence of oral candidiasis, hyperpigmentation, Kaposi's sarcoma, xerosis, folliculitis, and herpes zoster among patients with low CD4 cell counts, which was similar to many previous studies (3, 6, 9, 14, 20) .
Here, we presented the types of skin diseases, as well as their stages among Turkish HIV/AIDS patients. The results suggested that oral candidiasis, Kaposi's sarcoma, folliculitis, and herpes zoster are useful clinical predictors of HIV infection or signs of the presence of advanced HIV infection. Dermatological manifestations may be the first clue of an HIV infection and may also be helpful in monitoring the immune status of the patient. 
